Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN

Ethical Issues in Clinical Research. Getting an IRB approval and role of NHRC

Experience of doing clinical research in Nepal

Ethical Issues in Clinical Research. Getting an IRB approval and role of NHRC

Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer

Challenges to developing the quality of complex cancer surgery in LMICs

The concept of time toxicity: A patient's perspective

Defining value based care for LMICs

Cancer survivors' stories: An African perspective

ESMO 2022: Breast and ovarian trial analysis

ERMES study suggests a strategy of de-escalation with only cetuximab in first line therapy for RAS and BRAF wild type mCRC

Neoadjuvant immunotherapy improves outlook in high-risk melanoma